Tyler W. Buckner

Tyler W. Buckner

Auto-generated profile, based on publicly available information

Tyler W. Buckner

University of Colorado School of Medicine

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2017 in Haemophilia
Verified
Journal Article
Open access
PDF file
MWM. Witkop
M. Witkop
ANA. Neff
A. Neff
TBT. W. Buckner
T. W. Buckner
MWM. Wang
M. Wang
KBK. Batt
K. Batt
CKC. L. Kempton
C. L. Kempton
Introduction: Haemophilia is characterized by frequent haemarthrosis, leading to acute/chronic joint pain.Aim: To assess self‐reported prevalence, description and management of pain in adult males with mild‐to‐severe haemophilia and history of joint pain/bleeding.Methods: Participants completed a pain survey and five patient‐reported outcome instruments assessing pain, functional impairment and health‐related quality of life (HRQoL).Results: Of 381 participants enrolled, median age was 34 years; 77% had haemophilia A, 71% had severe disease and 65% were overweight/obese. Many (56%) were not receiving routine infusions; 30% never received routine infusions. During the prior 6 months, 20% experienced acute pain, 34% chronic pain and 32% both acute/chronic pain. Subjects with both acute/chronic pain (vs. none, acute or chronic) were more likely to be depressed (30% vs. 0–15%), obese (35% vs. 20–29%) and have lower HRQoL (mean EQ‐5D visual analog scale, 69 vs. 83–86) and function (median overall Hemophilia Activities List, 60 vs. 88–99). Most common analgesics used for acute/chronic pain during the prior 6 months were acetaminophen (62%/55%) and non‐steroidal anti‐inflammatory drugs (34%/49%); most common non‐pharmacologic strategies were ice (65%/33%) and rest (51%/33%). Hydrocodone‐acetaminophen was the most common opioid for both acute/chronic pain (30%); other long‐acting opioids were infrequently used specifically for chronic but not acute pain (morphine, 7%; methadone, 6%; fentanyl patch, 2%).Conclusion: Patients with chronic pain, particularly those with both acute/chronic pain, frequently experience psychological issues, functional disability and reduced HRQoL. Treatment strategies for acute pain (e.g. routine infusions to prevent bleeding) and for chronic pain (e.g. long‐acting opioids) may be underused.

23 November 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JZJian Zuo
Jian Zuo
JTJason Treadaway
Jason Treadaway
TBTyler W. Buckner
Tyler W. Buckner
Bernd FritzschBernd Fritzsch
Bernd Fritzsch
The α9 acetylcholine receptor (α9 AChR) is specifically expressed in hair cells of the inner ear and is believed to be involved in synaptic transmission between efferent nerves and hair cells. Using a recently developed method, we modified a bacterial artificial chromosome containing the mouse α9 AChR gene with a reporter gene encoding green fluorescent protein (GFP) to generate transgenic mice. GFP expression in transgenic mice recapitulated the known temporal and spatial expression of α9 AChR. However, we observed previously unidentified dynamic changes in α9 AChR expression in cochlear and vestibular sensory epithelia during neonatal development. In the cochlea, inner hair cells persistently expressed high levels of α9 AChR in both the apical and middle turns, whereas both outer and inner hair cells displayed dynamic changes of α9 AChR expression in the basal turn. In the utricle, we observed high levels of α9 AChR expression in the striolar region during early neonatal development and high levels of α9 AChR in the extrastriolar region in adult mice. Further, simultaneous visualization of efferent innervation and α9 AChR expression showed that dynamic expression of α9 AChR in developing hair cells was independent of efferent contacts. We propose that α9 AChR expression in developing auditory and vestibular sensory epithelia correlates with maturation of hair cells and is hair-cell autonomous.

2 March 2018 in European Journal of Haematology
Verified
Journal Article
Open access
PDF file
TBTyler W. Buckner
Tyler W. Buckner
KBKatharine Batt
Katharine Batt
DQDoris Quon
Doris Quon
MWMichelle Witkop
Michelle Witkop
MRMichael Recht
Michael Recht
CKChristine L. Kempton
Christine L. Kempton
Introduction: Pain, functional impairment, anxiety, and depression associated with joint disease may affect health‐related quality of life (HRQoL) in people with hemophilia.Objective: To report detailed patient‐reported outcomes (PRO) assessments related to HRQoL in participants in the Pain, Functional Impairment, and Quality of Life (P‐FiQ) study.Methods: Pain and HRQoL were assessed via PRO instruments in US adult males with hemophilia A or B and a history of joint pain or bleeding. PRO instruments included EQ‐5D‐5L with visual analog scale, Brief Pain Inventory v2 Short Form, SF‐36v2, and Hemophilia Activities List. Instrument domain and item responses were described.Results: Responses were collected from 381 adult males with a median age of 34 years. Pain was observed across instruments and affected daily activities and quality of life. Respondents reported functional impairment that limited the kind of work and activities they participated in, with activities involving the lower extremities being most affected. A high prevalence of mental health disorders was identified across instruments.Conclusions: Pain and HRQoL were evaluated using multiple PRO instruments, which vary in timescales of assessment and levels of detail. More consistent clinical assessments and patient dialog regarding pain and aspects of HRQoL may help drive improved outcomes.


8 February 2022 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
BKBrendan Kleiboer
Brendan Kleiboer
MLMarcus A. Layer
Marcus A. Layer
LCLorraine A. Cafuir
Lorraine A. Cafuir
ACAdam Cuker
Adam Cuker
MEMiguel Escobar
Miguel Escobar
TBTyler W. Buckner
Tyler W. Buckner

5 March 2018 in European Journal of Haematology
Verified
Journal Article
Open access
PDF file
TBTyler W. Buckner
Tyler W. Buckner
MWMichelle Witkop
Michelle Witkop
CGChristine Guelcher
Christine Guelcher
RSRobert Sidonio
Robert Sidonio
CKCraig M. Kessler
Craig M. Kessler
DCDavid L. Cooper
David L. Cooper
Introduction: Health‐related quality of life (HRQoL) is impaired in patients with hemophilia; however, the impact in mild/moderate hemophilia B and affected women is not well characterized.Objective: To evaluate factors that affect HRQoL in adults with hemophilia B and caregivers of affected children.Methods: US adult patients and caregivers of affected children completed distinct ~1‐hour online surveys including patient‐reported outcome instruments.Results: In total, 299 adult patients and 150 caregivers participated. Adults with moderate hemophilia reported poorer health status (median EQ‐5D‐5L index score, 0.63) than those with mild (0.73) or severe (0.74) hemophilia. Women reported greater pain severity than men on the Brief Pain Inventory v2 Short Form (median, 7.00 vs 5.00). Based on the Patient Health Questionnaire, mild or worse depression was observed in >50% of adult respondents, and depression was reported more often in those with moderate and severe hemophilia vs those with mild hemophilia. Most caregivers reported at least mild depression.Conclusion: Pain, functional impairment, and depression/anxiety are present at higher‐than‐expected levels in individuals with hemophilia B. The large proportion of individuals with mild/moderate hemophilia and women with reduced health status suggests significant unmet needs in this population.